Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle Westergren Hendel

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Acta Oncologica (Stockholm, Sweden)|April 26, 2017
Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEPIben Spanggaard, Karin Dahlstroem, Line Laessoee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 14, 2021
Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patientsNeel Maria Helvind, Catalina Aurora Aros Mardones, Lisbet Rosenkrantz Hölmich, et al.
BMJ Open|January 30, 2023
Randomised phase II trial of stereotactic body radiotherapy in combination with <b>check</b>point inhibitors in metastatic castration-resistant <b>pro</b>state cancer (CheckPRO): a study protocolNicklas Juel Spindler, Gitte Fredberg Persson, Susann Theile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 RegimenRikke Andersen, Marco Donia, Eva Ellebaek, et al.
Annals of Surgical Oncology|February 8, 2023
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 PatientsNeel Maria Helvind, Marie Brinch-Møller Weitemeyer, Annette Hougaard Chakera, et al.
Oncoimmunology|December 8, 2018
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot studyMagnus Pedersen, Marie Christine Wulff Westergaard, Katy Milne, et al.
Nature Medicine|March 9, 2022
Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanomaJulie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, et al.
Nature Medicine|December 10, 2021
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanomaJulie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Acta Oncologica (Stockholm, Sweden)|April 26, 2017
Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEPIben Spanggaard, Karin Dahlstroem, Line Laessoee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 14, 2021
Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patientsNeel Maria Helvind, Catalina Aurora Aros Mardones, Lisbet Rosenkrantz Hölmich, et al.
BMJ Open|January 30, 2023
Randomised phase II trial of stereotactic body radiotherapy in combination with <b>check</b>point inhibitors in metastatic castration-resistant <b>pro</b>state cancer (CheckPRO): a study protocolNicklas Juel Spindler, Gitte Fredberg Persson, Susann Theile, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 RegimenRikke Andersen, Marco Donia, Eva Ellebaek, et al.
Annals of Surgical Oncology|February 8, 2023
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 PatientsNeel Maria Helvind, Marie Brinch-Møller Weitemeyer, Annette Hougaard Chakera, et al.
Oncoimmunology|December 8, 2018
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot studyMagnus Pedersen, Marie Christine Wulff Westergaard, Katy Milne, et al.
Nature Medicine|March 9, 2022
Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanomaJulie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, et al.
Nature Medicine|December 10, 2021
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanomaJulie Westerlin Kjeldsen, Cathrine Lund Lorentzen, Evelina Martinenaite, et al.
Pageof 3